BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25442283)

  • 1. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
    Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
    Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.
    Zheng X; Chen S; Yang Q; Cai J; Zhang W; You H; Xing J; Dong Y
    Cancer Biol Ther; 2015; 16(9):1407-14. PubMed ID: 26176734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
    Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
    Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway.
    Tang XL; Yan L; Zhu L; Jiao DM; Chen J; Chen QY
    J Pharmacol Sci; 2017 Sep; 135(1):1-7. PubMed ID: 28939129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.
    Zhang W; Zheng X; Meng T; You H; Dong Y; Xing J; Chen S
    J Drug Target; 2017 Mar; 25(3):255-263. PubMed ID: 27718638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway.
    Liu L; Meng T; Zheng X; Liu Y; Hao R; Yan Y; Chen S; You H; Xing J; Dong Y
    Mol Cancer Ther; 2019 Dec; 18(12):2457-2468. PubMed ID: 31488699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction.
    Zhong W; Sun B; Gao W; Qin Y; Zhang H; Huai L; Tang Y; Liang Y; He L; Zhang X; Tao H; Chen S; Yang W; Yang L; Liu Y; Liu H; Zhou H; Sun T; Yang C
    EBioMedicine; 2018 Nov; 37():246-258. PubMed ID: 30361065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
    Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
    Chen SY; Zheng XW; Cai JX; Zhang WP; You HS; Xing JF; Dong YL
    Int J Oncol; 2016 Jul; 49(1):294-304. PubMed ID: 27211281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells.
    Wang X; Wang C; Zhang L; Li Y; Wang S; Wang J; Yuan C; Niu J; Wang C; Lu G
    Anticancer Drugs; 2015 Feb; 26(2):210-23. PubMed ID: 25419632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
    Li G; Xu D; Sun J; Zhao S; Zheng D
    Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.
    Chen S; Dong Q; Hu S; Cai J; Zhang W; Sun J; Wang T; Xie J; He H; Xing J; Lu J; Dong Y
    Mol Biosyst; 2014 Feb; 10(2):294-303. PubMed ID: 24292090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrine reversed multidrug resistance of breast cancer MCF-7/ADR cells through PI3K/AKT signaling pathway.
    Zhou BG; Wei CS; Zhang S; Zhang Z; Gao HM
    J Cell Biochem; 2018 May; 119(5):3885-3891. PubMed ID: 29130495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
    Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
    Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.
    Ye T; Chen R; Zhou Y; Zhang J; Zhang Z; Wei H; Xu Y; Wang Y; Zhang Y
    Bioengineered; 2022 May; 13(5):11646-11655. PubMed ID: 35505656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.
    Chang X; Liu Z; Cao S; Bian J; Zheng D; Wang N; Guan Q; Wu Y; Zhang W; Li Z; Zuo D
    Toxicol Appl Pharmacol; 2022 Feb; 436():115883. PubMed ID: 35031325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreducible and acid-labile polydiethylenetriamines with sequential degradability for efficient transgelin-2 siRNA delivery.
    Wang P; Yan Y; Sun Y; Zhang R; Huo C; Li L; Wang K; Dong Y; Xing J
    J Mater Chem B; 2019 Nov; 7(44):6994-7005. PubMed ID: 31625545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.